Non-Alcoholic Fatty Liver Disease, Hepatic System
16. Jul 2018
ADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis.
BACKGROUND AND AIM:
Given the high global prevalence of non-alcoholic fatty liver disease (NAFLD), the need for relevant non-invasive biomarkers and algorithms to accurately stage disease severity is a critical unmet medical need. Identifying those with advanced fibrosis (≥F3) is the most crucial, …
Read the publication
Journal:
Authors:
- Daniels SJ,
- Leeming DJ,
- Eslam M,
- Hashem AM,
- Nielsen MJ,
- Krag A,
- Karsdal MA,
- Grove JI,
- Guha IN,
- Kawaguchi T,
- Torimura T,
- McLeod D,
- Akiba J,
- Kaye P,
- de Boer B,
- Aithal GP,
- Adams LA,
- George J,